WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018

May 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-05-09

Reporting Person: FEDERICI WILLIAM J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-09	Common Stock	M	52000.00	$16.045	Acquired	247019.3342	Direct
2018-05-09	Common Stock	S	52000.00	$87.14	Disposed	195019.3342	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-09	Stock Options (Right to Buy)	$16.045	M	52000.00	Disposed	2019-02-24	Common Stock (52000.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1046.4185	Indirect
Common Stock	17060.5586	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $86.95 USD to $87.80 USD; the price reported above reflects the weighted average sale price.

F2: This award vests in 4 equal annual installments beginning on 2/24/2010.